Identification of clinical and urine biomarkers for uncomplicated urinary tract infection using machine learning algorithms.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 12 2019
Historique:
received: 26 05 2019
accepted: 19 11 2019
entrez: 25 12 2019
pubmed: 25 12 2019
medline: 11 11 2020
Statut: epublish

Résumé

Women with uncomplicated urinary tract infection (UTI) symptoms are commonly treated with empirical antibiotics, resulting in overuse of antibiotics, which promotes antimicrobial resistance. Available diagnostic tools are either not cost-effective or diagnostically sub-optimal. Here, we identified clinical and urinary immunological predictors for UTI diagnosis. We explored 17 clinical and 42 immunological potential predictors for bacterial culture among women with uncomplicated UTI symptoms using random forest or support vector machine coupled with recursive feature elimination. Urine cloudiness was the best performing clinical predictor to rule out (negative likelihood ratio [LR-] = 0.4) and rule in (LR+ = 2.6) UTI. Using a more discriminatory scale to assess cloudiness (turbidity) increased the accuracy of UTI prediction further (LR+ = 4.4). Urinary levels of MMP9, NGAL, CXCL8 and IL-1β together had a higher LR+ (6.1) and similar LR- (0.4), compared to cloudiness. Varying the bacterial count thresholds for urine culture positivity did not alter best clinical predictor selection, but did affect the number of immunological predictors required for reaching an optimal prediction. We conclude that urine cloudiness is particularly helpful in ruling out negative UTI cases. The identified urinary biomarkers could be used to develop a point of care test for UTI but require further validation.

Identifiants

pubmed: 31873085
doi: 10.1038/s41598-019-55523-x
pii: 10.1038/s41598-019-55523-x
pmc: PMC6928162
doi:

Substances chimiques

Biomarkers 0
CXCL8 protein, human 0
Immunologic Factors 0
Interleukin-1beta 0
Interleukin-8 0
LCN2 protein, human 0
Lipocalin-2 0
MMP9 protein, human EC 3.4.24.35
Matrix Metalloproteinase 9 EC 3.4.24.35

Banques de données

ISRCTN
['ISRCTN65200697']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19694

Subventions

Organisme : Department of Health
ID : II-LA-0712-20006
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N023145/1
Pays : United Kingdom

Références

Indian J Ophthalmol. 2009 May-Jun;57(3):217-21
pubmed: 19384017
Int J Neuropsychopharmacol. 2011 Oct;14(9):1147-55
pubmed: 21466745
Kidney Int. 2005 Jul;68(1):62-70
pubmed: 15954896
Pediatr Nephrol. 2011 Aug;26(8):1263-8
pubmed: 21556719
Dtsch Arztebl Int. 2010 May;107(21):361-7
pubmed: 20539810
Ann Lab Med. 2014 Sep;34(5):354-9
pubmed: 25187887
J Spinal Cord Med. 2009;32(5):568-73
pubmed: 20025153
J Am Soc Nephrol. 2013 Dec;24(12):2002-9
pubmed: 24179164
Biochem Med (Zagreb). 2014 Feb 15;24(1):89-104
pubmed: 24627718
Drug Discov Today. 2015 Mar;20(3):318-31
pubmed: 25448759
Ci Ji Yi Xue Za Zhi. 2017 Jul-Sep;29(3):131-137
pubmed: 28974905
Br J Gen Pract. 2017 Dec;67(665):e830-e841
pubmed: 29158245
J Biol Chem. 2001 Oct 5;276(40):37258-65
pubmed: 11486009
Pediatr Res. 2016 Jun;79(6):934-9
pubmed: 26885759
Kidney Int. 2017 Jul;92(1):179-191
pubmed: 28318629
J Chem Inf Model. 2019 Apr 22;59(4):1668-1679
pubmed: 30840454
Mol Ther Nucleic Acids. 2018 Dec 7;13:568-579
pubmed: 30439645
Pediatrics. 2017 Dec;140(6):
pubmed: 29146619
Nat Rev Genet. 2015 Jun;16(6):321-32
pubmed: 25948244
Cent Eur J Immunol. 2016;41(3):260-267
pubmed: 27833443
J Med Syst. 2016 Apr;40(4):108
pubmed: 26922592
PLoS One. 2018 Mar 7;13(3):e0194085
pubmed: 29513742
Br J Gen Pract. 2018 Apr;68(669):e268-e278
pubmed: 29483078
Adv Exp Med Biol. 2018;1047:71-80
pubmed: 28980274
Front Aging Neurosci. 2017 Oct 06;9:329
pubmed: 29056906
Br J Gen Pract. 2006 Aug;56(529):606-12
pubmed: 16882379
Fam Pract. 2017 Aug 1;34(4):392-399
pubmed: 28334777
BMC Bioinformatics. 2016 Dec 6;17(1):496
pubmed: 27923348
Female Pelvic Med Reconstr Surg. 2017 Mar/Apr;23(2):101-107
pubmed: 28106649
BMC Fam Pract. 2014 Nov 25;15:187
pubmed: 25425162
Health Technol Assess. 2009 Mar;13(19):iii-iv, ix-xi, 1-73
pubmed: 19364448
Neurosci Biobehav Rev. 2012 Apr;36(4):1140-52
pubmed: 22305994
Pediatr Nephrol. 2017 Nov;32(11):2079-2087
pubmed: 28756475
Int J Med Inform. 2007 Apr;76(4):289-96
pubmed: 16469531
Comput Struct Biotechnol J. 2017 Jan 08;15:104-116
pubmed: 28138367
Cytokine. 2017 Mar;91:38-43
pubmed: 27997859
Nat Rev Immunol. 2015 Oct;15(10):655-63
pubmed: 26388331

Auteurs

Amal A H Gadalla (AAH)

Division of Population Medicine, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom. GadallaA1@cardiff.ac.uk.

Ida M Friberg (IM)

Division of Infection & Immunity, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.

Ann Kift-Morgan (A)

Division of Infection & Immunity, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.

Jingjing Zhang (J)

Division of Infection & Immunity, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.

Matthias Eberl (M)

Division of Infection & Immunity, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.
Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom.

Nicholas Topley (N)

Division of Infection & Immunity, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.
Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom.

Ian Weeks (I)

Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom.
Clinical Innovation Hub, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.

Simone Cuff (S)

Division of Infection & Immunity, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.
Systems Immunity Research Institute, Cardiff University, Cardiff, United Kingdom.
Clinical Innovation Hub, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.

Mandy Wootton (M)

Specialist Antimicrobial Chemotherapy Unit, Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, United Kingdom.

Micaela Gal (M)

Division of Population Medicine, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.

Gita Parekh (G)

Mologic Ltd., Bedford Technology Park, Thurleigh, Bedford, United Kingdom.

Paul Davis (P)

Mologic Ltd., Bedford Technology Park, Thurleigh, Bedford, United Kingdom.

Clive Gregory (C)

Division of Population Medicine, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.

Kerenza Hood (K)

Centre for Trials Research, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.

Kathryn Hughes (K)

Division of Population Medicine, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.

Christopher Butler (C)

Division of Population Medicine, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.

Nick A Francis (NA)

Division of Population Medicine, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom.
Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH